#Japan #Tokyo #medical technology #EverBridge Group #Cosmotec

A Game-Changing Collaboration: EverBridge Group and Cosmotec

On September 15, 2025, EverBridge Group made a significant announcement regarding its new exclusive marketing partnership with Cosmotec Inc., a wholly-owned subsidiary of M3, Inc. This strategic alliance is poised to revolutionize the landscape for medical devices in the Japanese market.

Strengthening Market Presence

This partnership marks a crucial step in EverBridge’s efforts to expand its global footprint, highlighting their leadership in R&D, strict regulatory compliance, and a value-driven ecosystem collaboration. According to Jay Wang, CEO of EverBridge Group, "Our digital marketing model not only offers efficiency and accessibility but aligns with our vision for equitable healthcare innovation."

The collaboration is expected to leverage the advanced digital marketing platform from Cosmotec, facilitating international medical devices in reaching Japanese clinicians effectively. This is crucial as medical professionals increasingly seek innovative therapeutic solutions that cater to Japan’s unique healthcare landscape. Suguru Ominato, CEO of Cosmotec, remarked, "EverBridge's product portfolio demonstrates exceptional clinical efficacy and user-friendly design, perfectly aligning with the aspirations of Japanese doctors for advanced treatment options."

Transformative Efforts in Healthcare

This partnership aims to do more than just create market access; it also intends to put the patient at the center of its agenda. By integrating M3's academic platforms with local marketing expertise, EverBridge anticipates enhancing the adoption of groundbreaking medical devices across Japan. The synergy created by this partnership is set to ease the barriers to advanced care, highlighting innovation and collaboration within the global R&D ecosystem as central to their globalization efforts.

About EverBridge Group

EverBridge Group stands tall as a leading medical technology company in Asia, dedicated to providing cutting-edge, high-quality, and affordable medical technologies worldwide. The company is actively expanding its product portfolio across three major therapeutic areas: peripheral vascular, neuroscience, and oncology. Supported by six specialized R&D and lean manufacturing centers, EverBridge offers top-tier OEM/ODM services in areas such as balloons, catheters, stents, surface engineering, and active medical devices.

Through close collaborations with leading companies worldwide, EverBridge is successfully bridging innovations in medical technologies from Asia to the global stage. They are committed to enhancing treatment options for healthcare professionals and patients globally through advanced and accessible solutions.

For more in-depth information about EverBridge and its offerings, please visit their official website at www.everbridgemed.com.

This partnership between EverBridge Group and Cosmotec Inc. is more than a business transaction; it embodies a commitment to improving healthcare outcomes in Japan and beyond through innovation and collaboration. As both companies gear up for this journey, the potential for advances in medical technology accessibility hangs in anticipation.